The mechanisms, diagnosis, and management of severe asthma in adults

  title={The mechanisms, diagnosis, and management of severe asthma in adults},
  author={Stephen T Holgate and Riccardo Polosa},
  journal={The Lancet},

Figures from this paper

Severe asthma: an expanding and mounting clinical challenge.

  • M. BellW. Busse
  • Medicine, Biology
    The journal of allergy and clinical immunology. In practice
  • 2013

An overview of chronic severe asthma

  • R. Polosa
  • Medicine
    Internal medicine journal
  • 2008
In this review, a diagnostic and therapeutic overview of CSA is provided for the benefit of those who have a specific interest in this problematic condition.

Managing patients with chronic severe asthma: rise to the challenge.

Severe asthma: how can we differentiate phenotypes?

  • R. Louis
  • Medicine
    Swiss medical weekly
  • 2009
A cluster analysis has identified two clusters specific to refractory asthma: an early onset symptom- Predominant asthma and a late onset inflammation-predominant form.

Severe Bronchial Asthma in the era of biological treatments

Omalizumab contributes to reduction in exacerbation rates, fewer emergency department visits and asthma related hospitalizations, better asthma symptom control, reduction in ICS or oral CS dose and improvement in asthma-related quality of life (QoL).


Evidence is emerging for considerable variability in the pattern of inflammation, thus indicating phenotypic differences that may influence treatment responses, and a key and expanding role for viral respiratory infections in these processes.

What goes up must come down: biomarkers and novel biologicals in severe asthma

  • B. HilveringI. Pavord
  • Medicine, Biology
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • 2015
The future will be identification of potentially responsive patients on the basis of raised biomarkers and targeted treatment with specific cytokine blockade that has a direct effect on the biomarkers.

S100A8/A9: a mediator of severe asthma pathogenesis and morbidity?

It is hypothesize that this capacity suggests S100A8/A9 could underpin chronic airway inflammation and airway remodeling in asthma by inducing effector responses of resident and infiltrating airway cells.

Stratified medicine in selecting biologics for the treatment of severe asthma

More basic science work is required to improve the current understanding of severe asthma pathophysiology and proof-of-concept clinical studies are required to explore relevant biomolecular targets in this small subset of patients.

Childhood asthma in adults

To impact prevalence, morbidity and mortality, research needs to address whether steroid insensitivity is playing a role or are there other physiological mechanismsPlaying a role.



Severe asthma: an overview.

Severe asthma in adults.

  • S. Wenzel
  • Medicine, Biology
    American journal of respiratory and critical care medicine
  • 2005
Treatment of severe asthma remains problematic, with corticosteroids remaining the most effective therapy, however, 5-lipoxygenase inhibitors, anti-IgE, and immunomodulatory drugs are also likely to have a place in treatment.

The influence of smoking on the treatment response in patients with asthma

The clinical evidence for corticosteroid resistance in smokers with asthma is summarized, the mechanisms which could be responsible and potential management of this resistance are considered, and alternative or additional therapies are needed for individuals with asthma who are unable to quit smoking.

Corticosteroid-insensitive asthma: molecular mechanisms.

In conclusion, elucidation of the cause for the relative lack of corticosteroid response in this subgroup of asthmatic individuals may have important implications for other diseases.

Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities.

Natural history of aspirin‐induced asthma

There is a subset of patients with bronchial asthma who are susceptible to disease exacerbation upon receiving aspirin and other nonsteroidal anti-inflammatory drugs, associated with alterations in arachidonate metabolism and cysteinyl-leukotriene overproduction, which develops in a similar characteristic way all over Europe.

Clinical phenotypes of asthma.

  • E. Bel
  • Medicine, Biology
    Current opinion in pulmonary medicine
  • 2004
The classic phenotype of IgE-mediated asthma starting in childhood is now clearly defined, and many other phenotypes of asthma in childhood as well in adulthood are being recognized.